Clinical Trials Browser

Phase 1/2 × Esophageal Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT05937438 2025-01-29

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

Phase 1/2 Recruiting

Gastrointestinal

Esophageal Neoplasms

NCT05777707 2023-03-21

Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma

Phase 1/2 Unknown

Gastrointestinal

Esophageal Neoplasms